Roberto Badagliacca

Pubblicazioni

Titolo Pubblicato in Anno
Choosing among β-blockers in heart failure patients according to β-receptors' location and functions in the cardiopulmonary system PHARMACOLOGICAL RESEARCH 2020
Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension JACC: CARDIOVASCULAR IMAGING 2020
Diabetic cardiomiopathy progression is triggered by miR122-5p and involves extracellular matrix: A 5-Year prospective study JACC. CARDIOVASCULAR IMAGING 2020
Intra-aortic balloon counterpulsation timing: A new numerical model for programming and training in the clinical environment COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2020
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension ARTHRITIS RESEARCH & THERAPY 2020
Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension CHEST 2020
Imaging risk in pulmonary arterial hypertension EUROPEAN RESPIRATORY JOURNAL 2020
Pulmonary vasodilators. beyond the bounds of pulmonary arterial hypertension therapy in COVID-19 PULMONARY CIRCULATION 2020
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. an analysis from the MECKI score research group EUROPEAN JOURNAL OF INTERNAL MEDICINE 2020
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database INTERNATIONAL JOURNAL OF CARDIOLOGY 2020
Right ventricular dyssynchrony. from load-independent right ventricular function to wall stress in severe pulmonary arterial hypertension PULMONARY CIRCULATION 2020
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension. THE JOURNAL OF HEART AND LUNG TRANSPLANTATION 2020
The importance of right ventricular evaluation in risk assessment and therapeutic strategies: raising the bar in pulmonary arterial hypertension INTERNATIONAL JOURNAL OF CARDIOLOGY 2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial JOURNAL OF TRANSLATIONAL MEDICINE 2020
Beta-blockers in heart failure prognosis. lessons learned by MECKI score group papers EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2020
The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension. THE JOURNAL OF HEART AND LUNG TRANSPLANTATION 2019
Exercise physiology in pulmonary hypertension patients with and without congenital heart disease EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2019
Heart failure prognosis over time. how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years EUROPEAN JOURNAL OF HEART FAILURE 2019
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction EUROPEAN JOURNAL OF HEART FAILURE 2019
Exercise energy expenditure in patients with idiopathic pulmonary arterial hypertension: impact on clinical severity and survival RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY 2019

ERC

  • LS4_10

KET

  • Big data & computing
  • Life-science technologies & biotechnologies

Interessi di ricerca

Ipertensione polmonare; insufficienza cardiaca

Keywords

ipertensione polmonare

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma